<DOC>
	<DOCNO>NCT02066077</DOCNO>
	<brief_summary>1 . To determine influence factor modify electroconvulsive therapy ( MECT ) ; 2 . To determine influence factor reversibility cognitive impairment cause MECT ; 3 . To determine duration efficacy MECT affect factor .</brief_summary>
	<brief_title>The Efficacy And Cognitive Impairment Of Modified Electroconvulsive Therapy</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Etomidate</mesh_term>
	<criteria>Aged 18 year ( informed consent get ) , male female Meet International Classification Diseases10 ( ICD10 ) diagnostic criterion depression Scored 18 HAMD Scale include 17 item Clinical Global Impression ( CGI ) severity score â‰¥ 4 Provided write informed consent Any depressive disorder due major depressive disorder Meet diagnosis criterion Diagnostic Statistical Manual Mental DisordersIVTest Revision ( DSMIVTR ) Axis I With history acute chronic renal failure , liver cirrhosis active hepatopathy With clinically significant abnormal result laboratory test , consider impact treatment efficacy safety participant With history severe unstable physical disease include nervous system disease myocardial infarction Undergoing alcoholism alcohol ( substance ) abuse 30 day 6 month trial With response previous ECT treatment Received transcranial magnetic stimulation treatment last 6 month Allergic propofol , etomidate succinylcholine chloride During pregnancy lactation With history stroke last month Enrolled clinical trial 30 day prior baseline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Modified Electroconvulsive Therapy</keyword>
	<keyword>Cognition</keyword>
	<keyword>Memory</keyword>
</DOC>